CoChat

High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance

Open access
Towers, R, Naftali, T, Gabay, G, Carlebach, M, Klein, A, Novis, B · 2005 · Clinical and Experimental Immunology
Cited by 52

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Summary: Up to 20% of Crohn's disease (CD) patients respond poorly to glucocorticoids (GC). A product of an alternative splicing of the glucocorticoid receptor (GR) premRNA, GRβ, may play a role as a dominant inhibitor of the glucocorticoid response. Increasing evidence suggests that inflammatory cytokines such as interleukin (IL)-18 alternate the splicing of the primary transcript between the two isoforms GRβ and GRα in hGR gene of CD patients. The aim of this study is to assess the expression of GRα and GRβ in patients with CD and to look for a possible correlation between these receptors and the response to glucocorticoid treatment. Forty-two CD patients and 17 healthy volunteers were studied. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) was performed using real-time PCR techniques. Serum IL-18 protein levels were measured by enzyme-linked immunosorbent assay (ELISA). The amount of hGRα-mRNA in patients in remission was significantly lower than in controls (P < 0·05). The amount of hGRβ-mRNA was significantly higher in GC-resistant patients in the active stage of disease compared with all other groups (P < 0·05). Patients in the active stage of the disease had higher levels of IL-18 than patients in remission and both had higher levels than controls (P < 0·05). The amounts of IL-18 were directly correlated with the amount of hGRβ mRNA in GC-resistant patients with an active disease. High levels of hGRβ might be connected to GC resistance. IL-18 might participate in the alternative splicing of the hGR preliminary mRNA of CD patients. The results support the theory that augmented hGRβ mRNA expression level in PBMC is connected with GC-resistance of CD patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2249.2005.02846.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 52

Metadata

Authors
Towers, R., Naftali, T., Gabay, G., Carlebach, M., Klein, A., & Novis, B.
Venue
Clinical and Experimental Immunology
Published
2005-06-16
Volume
141
Issue
2
Pages
357-362
ISSN
  • 0009-9104 (ISSN-L)
  • 1365-2249
OpenAlex
W1988948608
Cited by
52
References
1
FWCI
1.85
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance. https://app.cochat.ai/papers/10.1111/j.1365-2249.2005.02846.x
The paper
Towers, R., Naftali, T., Gabay, G., Carlebach, M., Klein, A., & Novis, B. (2005). High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance. Clinical and Experimental Immunology. https://doi.org/10.1111/j.1365-2249.2005.02846.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.